Gastroenterologian yksikkö

2023

Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study

Int PSC Study Grp, Schregel, I., Ramos, G. P., Ioannou, S., Culver, E., Färkkilä, M. & Schramm, C., Dec 2023, In: Clinical Gastroenterology and Hepatology. 21, 13, 6 p., 3448-3450.e3.

Research output: Contribution to journal › Letter › Scientific

Open Access

File

2021

Author's Reply: Fecal Microbiota Transplantation for Chronic Pouchitis: Promising Novel Therapeutic or Lost Cause?

Karjalainen, E. K., Renkonen-Sinisalo, L., Satokari, R., Mustonen, H., Ristimäki, A., Arkkila, P. & Lepistö, A. H., Jul 2021, In: Inflammatory Bowel Diseases. 27, 7, p. E79-E80 2 p.

Research output: Contribution to journal › Letter › Scientific

2020

Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease

Åberg, F., Puukka, P., Salomaa, V., Männistö, S., Lundqvist, A., Valsta, L., Perola, M., Jula, A. & Farkkila, M., Apr 2020, In: Clinical Gastroenterology and Hepatology. 18, 4, p. 995-+ 5 p.

Research output: Contribution to journal › Letter › Scientific

Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed

Keller, J. J., Vehreschild, M. J. G. T., Hvas, C. L., Jorgensen, S. M. D., Kupcinskas, J., Link, A., Mulder, C. J. J., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P., Apr 2020, In: United european gastroenterology journal. 8, 3, p. 353-354 2 p., 2050640620910847.

Research output: Contribution to journal › Letter › Scientific

Faecal banking at -20 degrees C facilitates faecal microbiota transplantation for recurrent Clostridioides difficile infection in clinical practice

Satokari, R., Pietilä, L., Mattila, E., Lahtinen, P. & Arkkila, P. E. T., 1 Sept 2020, In: Infectious Diseases. 52, 9, p. 662-665 4 p.

Research output: Contribution to journal › Letter › Scientific

Letter: faecal microbiota transplantation for irritable bowel syndrome-which improvements are required? Authors' reply

Lahtinen, P., Jalanka, J., Hartikainen, A., Mattila, E., Hillilä, M., Punkkinen, J., Koskenpato, J., Anttila, V.-J., Tillonen, J., Satokari, R. & Arkkila, P., Dec 2020, In: Alimentary Pharmacology & Therapeutics. 52, 11-12, p. 1754-1755 2 p.

Research output: Contribution to journal › Letter › Scientific

Letter: faecal microbiota transplantation for irritable bowel syndrome-room for improvement. Authors' reply

Lahtinen, P., Jalanka, J., Hartikainen, A., Mattila, E., Hillila, M., Punkkinen, J., Koskenpato, J., Anttila, V.-J., Tillonen, J., Satokari, R. & Arkkila, P., Sept 2020, In: Alimentary Pharmacology & Therapeutics. 52, 5, p. 925-926 2 p.

Research output: Contribution to journal › Letter › Scientific

Letter: faecal microbiota transplantation for irritable bowel syndrome. Authors' reply

Lahtinen, P., Jalanka, J., Hartikainen, A., Mattila, E., Hillilä, M., Punkkinen, J., Koskenpato, J., Anttila, V.-J., Tillonen, J., Satokari, R. & Arkkila, P., Aug 2020, In: Alimentary Pharmacology & Therapeutics. 52, 3, p. 557-558 2 p.

Research output: Contribution to journal › Letter › Scientific

Letter to the Editor: Moderate Alcohol Use in Fatty Liver Disease: Don't Throw the Cabernet Out With the Bathwater REPLY

Åberg, F., Färkkilä, M., Salomaa, V. & Jula, A., May 2020, In: Hepatology. 71, 5, p. 1888-1889 2 p.

Research output: Contribution to journal › Letter › Scientific

Open Access

File

2019

Insulin Resistance and Genetic Risk Predict Liver-Related Outcomes and Death in Nonalcoholic Fatty Liver Disease

Danford, C. J., Jiang, Z. G., Salomaa, V., Färkkilä, M., Jula, A., Männistö, S., Lundqvist, A., Valsta, L., Perola, M. & Åberg, F., Dec 2019, In: Hepatology communications. 3, 12, p. 1704-1705 2 p.

Research output: Contribution to journal › Letter › Scientific

Open Access

File

2018